logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

TTE.US is considering selling some of its renewable energy assets in Asia to help reduce debt.

date
13/11/2025
The iFinance APP learned that informed sources revealed that Total Energies (TTE.US) is considering selling part of its renewable energy assets in Asia to help reduce debt. The French group has hired advisors and is exploring interest from potential buyers. The sale of assets could be valued at several hundred million dollars.
Latest
3 m ago
The Ministry of Commerce has made the latest response on issues related to Anshi Semiconductor and Sino-US soybean trade.
4 m ago
Hongkong Land responds to "mass layoff in residential division": No specific information available to provide.
4 m ago
Rilatelpo peptide injection has a new indication in China and has been accepted for application.
4 m ago
On November 13th, the official website of the China Drug Administration (CDE) announced that the new indication application for the Glucagon-Dependent Insulinotropic Peptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) dual receptor agonist Tirzepatide injection of Eli Lilly (LLY.N) has been accepted. This is the third indication approved for the drug in China after receiving approval for another indication.
4 m ago
Yatong signed a contract with Guangzhou Huadu Automobile City Group to establish and operate the "Guangzhou Huadu Industrial Supply Chain Service Platform".
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.